Mark A Lemmon

Yale University

NIH Rank #3593
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$2.5M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#3,593
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.5M across 5 grants · National rank #3593.

Top grants by award amount

Mark A Lemmon's NIH grant portfolio, ranked by award amount.

  • 5R35GM122485-08R35
    Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases
    $770.5K
    award amount
  • 5R01CA244660-05R01
    Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling
    $643.7K
    award amount
  • 5R01CA248166-05R01
    Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses
    $502.3K
    award amount
  • 5R01CA198164-10R01
    Understanding EGF receptor activation by growth factors and oncogenic mutations
    $487.9K
    award amount
  • 5P50DE030707-05P50
    Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
    $110.8K
    award amount

Affiliation

Institutions that have administered grants for Mark A Lemmon.

Affiliated with Yale University (CT).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Yale University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3593
  6. 2024
    Entered Top 25% Nationally
    Ranked #3593